Joel M Reid, PhD

  • 7628 Citations
  • 45 Scopus h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joel M Reid is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 7628 Citations
  • 45 Scopus h-Index
  • 175 Article
  • 2 Comment/debate
  • 2 Letter

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

Jayaraman, S., Hou, X., Kuffel, M. J., Suman, V. J., Hoskin, T. L., Reinicke, K. E., Monroe, D. G., Kalari, K. R., Tang, X., Zeldenrust, M. A., Cheng, J., Bruinsma, E. S., Buhrow, S. A., McGovern, R. M., Safgren, S. L., Walden, C. A., Carter, J. M., Reid, J. M., Ingle, J. N., Ames, M. M. & 2 others, Hawse, J. R. & Goetz, M. P., May 19 2020, In : Breast Cancer Research. 22, 1, 51.

Research output: Contribution to journalArticle

Open Access
  • CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants

    Zhang, L., Sarangi, V., Moon, I., Yu, J., Liu, D., Devarajan, S., Reid, J. M., Kalari, K. R., Wang, L. & Weinshilboum, R., Jan 1 2020, (Accepted/In press) In : Clinical and translational science.

    Research output: Contribution to journalArticle

    Open Access
  • Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

    Davis, K. L., Fox, E., Merchant, M. S., Reid, J. M., Kudgus, R. A., Liu, X., Minard, C. G., Voss, S., Berg, S. L., Weigel, B. J. & Mackall, C. L., Apr 2020, In : The Lancet Oncology. 21, 4, p. 541-550 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits

    Chowdhury, U. R., Kudgus, R. A., Rinkoski, T. A., Holman, B. H., Bahler, C. K., Hann, C. R., Reid, J. M., Dosa, P. I. & Fautsch, M. P., Apr 2020, In : PloS one. 15, 4, e0231841.

    Research output: Contribution to journalArticle

    Open Access
  • Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)

    Schafer, E. S., Rau, R. E., Berg, S. L., Liu, X., Minard, C. G., Bishop, A. J. R., Romero, J. C., Hicks, M. J., Nelson, M. D., Voss, S., Reid, J. M., Fox, E., Weigel, B. J. & Blaney, S. M., Feb 1 2020, In : Pediatric Blood and Cancer. 67, 2, e28073.

    Research output: Contribution to journalArticle